125 related articles for article (PubMed ID: 37879405)
1. Pioneer Factor Foxa2 Mediates Chromatin Conformation Changes for Activation of Bile Acid Targets of FXR.
Hao Y; Han L; Wu A; Bochkis IM
Cell Mol Gastroenterol Hepatol; 2024; 17(2):237-249. PubMed ID: 37879405
[TBL] [Abstract][Full Text] [Related]
2. Pioneer factor Foxa2 mediates chromatin conformation changes in ligand-dependent activation of nuclear receptor FXR.
Hao Y; Han L; Wu A; Bochkis IM
bioRxiv; 2023 Mar; ():. PubMed ID: 36945375
[TBL] [Abstract][Full Text] [Related]
3. Pioneer factor Foxa2 enables ligand-dependent activation of type II nuclear receptors FXR and LXRα.
Kain J; Wei X; Reddy NA; Price AJ; Woods C; Bochkis IM
Mol Metab; 2021 Nov; 53():101291. PubMed ID: 34246806
[TBL] [Abstract][Full Text] [Related]
4. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
[TBL] [Abstract][Full Text] [Related]
5. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
6. FXR controls insulin content by regulating Foxa2-mediated insulin transcription.
Yan D; Lv M; Kong X; Feng L; Ying Y; Liu W; Wang X; Ma X
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119655. PubMed ID: 38135007
[TBL] [Abstract][Full Text] [Related]
7. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
8. Foxa2-dependent hepatic gene regulatory networks depend on physiological state.
Bochkis IM; Schug J; Rubins NE; Chopra AR; O'Malley BW; Kaestner KH
Physiol Genomics; 2009 Jul; 38(2):186-95. PubMed ID: 19417011
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X receptor activation mediates head-to-tail chromatin looping in the Nr0b2 gene encoding small heterodimer partner.
Li G; Thomas AM; Hart SN; Zhong X; Wu D; Guo GL
Mol Endocrinol; 2010 Jul; 24(7):1404-12. PubMed ID: 20444884
[TBL] [Abstract][Full Text] [Related]
10. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
[TBL] [Abstract][Full Text] [Related]
11. Pregnane X receptor is a target of farnesoid X receptor.
Jung D; Mangelsdorf DJ; Meyer UA
J Biol Chem; 2006 Jul; 281(28):19081-91. PubMed ID: 16682417
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice.
Lee J; Seok S; Yu P; Kim K; Smith Z; Rivas-Astroza M; Zhong S; Kemper JK
Hepatology; 2012 Jul; 56(1):108-17. PubMed ID: 22278336
[TBL] [Abstract][Full Text] [Related]
13. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC
Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067
[TBL] [Abstract][Full Text] [Related]
15. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
Moscovitz JE; Kong B; Buckley K; Buckley B; Guo GL; Aleksunes LM
Toxicol Appl Pharmacol; 2016 Nov; 310():60-67. PubMed ID: 27609522
[TBL] [Abstract][Full Text] [Related]
16. FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression.
Wang S; Feng R; Wang SS; Liu H; Shao C; Li Y; Link F; Munker S; Liebe R; Meyer C; Burgermeister E; Ebert M; Dooley S; Ding H; Weng H
Gut; 2023 Mar; 72(3):549-559. PubMed ID: 35444014
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress.
Bochkis IM; Rubins NE; White P; Furth EE; Friedman JR; Kaestner KH
Nat Med; 2008 Aug; 14(8):828-36. PubMed ID: 18660816
[TBL] [Abstract][Full Text] [Related]
18. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
19. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression.
Urizar NL; Dowhan DH; Moore DD
J Biol Chem; 2000 Dec; 275(50):39313-7. PubMed ID: 10998425
[TBL] [Abstract][Full Text] [Related]
20. Farnesoid X receptor regulates bile acid-amino acid conjugation.
Pircher PC; Kitto JL; Petrowski ML; Tangirala RK; Bischoff ED; Schulman IG; Westin SK
J Biol Chem; 2003 Jul; 278(30):27703-11. PubMed ID: 12754200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
